NovoCure (NVCR) Gross Profit Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.54% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 9.03% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.49% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.46% |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 13.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.44% |
| Dec 31, 2025 | 9.92% |
| Sep 30, 2025 | 6.55% |
| Jun 30, 2025 | 1.45% |
| Mar 31, 2025 | 1.98% |
| Dec 31, 2024 | 7.27% |
| Sep 30, 2024 | 5.01% |
| Jun 30, 2024 | 3.32% |
| Mar 31, 2024 | -1.09% |
| Dec 31, 2023 | -4.39% |
| Sep 30, 2023 | -2.98% |
| Jun 30, 2023 | 0.58% |
| Mar 31, 2023 | 6.18% |
| Dec 31, 2022 | 10.17% |
| Sep 30, 2022 | 13.55% |
| Jun 30, 2022 | 19.64% |
| Mar 31, 2022 | 27.09% |
| Dec 31, 2021 | 30.44% |
| Sep 30, 2021 | 31.18% |
| Jun 30, 2021 | 36.03% |
| Mar 31, 2021 | 47.30% |
| Dec 31, 2020 | 44.96% |
| Sep 30, 2020 | 43.95% |
| Jun 30, 2020 | 53.06% |
| Mar 31, 2020 | 49.34% |
| Dec 31, 2019 | 56.92% |
| Sep 30, 2019 | 87.12% |
| Jun 30, 2019 | 237.28% |
| Mar 31, 2019 | 119.32% |
| Dec 31, 2018 | 97.24% |
| Sep 30, 2018 | 140.47% |
| Jun 30, 2018 | 185.40% |
| Mar 31, 2018 | 195.67% |
| Dec 31, 2017 | 219.02% |
| Sep 30, 2017 | 169.39% |